Market Capitalization (MKT) under Consideration: Boston Scientific Corporation (NYSE:BSX), The Medicines Company (NASDAQ:MDCO)

Boston Scientific Corporation (NYSE:BSX)’s Analysis & Performances to Discover

On Friday, Shares of Boston Scientific Corporation flaunted -3.19% to reach at $35.80 during previous trading session. The company has experienced volume of 6,822,493 shares while on average the company has a capacity of trading 7.64M share.

Technical Look at Boston Scientific Corporation (NYSE:BSX): (Is this is BUY or SELL time?)

The Company holds the market capitalization of $51.17B along with 1.43B outstanding shares. Currently the stock price is moving -9.23% off from the highest level of twelve months and +44.41% above from twelve months low. For the stock, price target value has been calculated at $42.41.

BSX’s Snapshot:

Boston Scientific Corporation (NYSE:BSX) has shown weekly performance of 0.90%. Its yearly performance remained 39.25%. Year-to-date (YTD) performance of the stock was 44.41%. The stock “BSX” was trading at a distance of -1.15% from 20 days simple moving average, and its distance from 50 days simple moving average is -2.33% while it has a distance of 8.18% from the 200 days simple moving average. The company has Relative Strength Index (RSI 14) of 45.27 along with Average True Range (ATR 14) of 1.26. Its weekly and monthly volatility is 2.69%, 3.50% respectively. The company’s beta value is at 0.72. Analysts mean recommendation for the stock is 1.40. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.

Boston Scientific Corporation (NYSE:BSX)’s P/E ratio is 32.81. The company’s price to sales ratio for trailing twelve months is 5.29 and price to book ratio for most recent quarter is 5.98, whereas price to cash per share for the most recent quarter is 304.60. BSX’s price to free cash flow for trailing twelve months is 55.87. Its quick ratio for most recent quarter is 0.60 along with current ratio for most recent quarter of 0.80. Total debt to equity ratio of the company for most recent quarter is 0.80 whereas long term debt to equity ratio for most recent quarter is 0.58. Boston Scientific Corporation has a Return on Assets of 3.40%. The company currently has a Return on Equity of 8.90% and Return on Investment of 10.40%.

The Medicines Company (NASDAQ:MDCO)’s Analysis & Performances to Discover

Shares of The Medicines Company (NASDAQ:MDCO) showed a change of -3.54% over the last week and performed -10.73% over the last month while its year to date (YTD) performance revealed an activity trend of -30.29%. The stock price closed last trading at $19.06. The Medicines Company (MDCO) negotiated 4,884,585 shares and maintained an average volume of 1.09M shares.

The price target set for the stock is $46.45 and this sets up an interesting set of potential movement for the stock, according to data from FINVIZ’s analysis. With approx. 76.57M shares in outstanding, the company has a market cap of $1.46B as per the current valuation. Calculating the market cap is easy. Market capitalization is simply the value that can get when multiply all the outstanding shares of a stock by the price of a single share. MDCO has a beta of 1.05.

What is PEG Ratio?

PEG ratio or Price/Earnings-Growth ratio is an attempt to normalize the P/E ratio with the expected earnings growth rate of the company.


The PEG ratio acts as a measure of value that takes into account future growth. Using this metric, investors can gauge whether high-growth stocks may be undervalued, even if they don’t appear so with the more common P/E ratio.

Typically P/E ratios are backward looking while the earnings growth rate is a forward looking metric. Future P/E ratio will be different than the one we use today. You could project a future P/E ratio if you wish, but this will introduce further uncertainty in the calculations. Still, many investors are fond of using the concept of Forward P/E and Forward PEG ratio. I strongly advise against this.

Negative PEG Ratio Connotation

A negative PEG ratio does not imply that the stock is a bad investment. It just means that you need to consider other ways of looking at the stock before you can judge if this is a good investment or not.

Is It Overvalued? Look at the PEG Ratio of BSX, MDCO (PEG ratio used to determine a stock’s value while taking into account the earnings’ growth.)

BSX has a PEG ratio of 3.14 and MDCO has a PEG ratio of N/A.

Amber Dunlea

My Self Amber Dunlea and I’m working in the industry of financial news developer and adviser, performing my duties for over 5 years in the industry, stared my work as a adviser, working experience with the seniors I become the major adviser and financial news reporter behind “stocks news point” with a vision to increase the benefits in the shape or profit and by introducing new customers, I personally like to show my interest in the business development and adviser, now I am the major news reporter/adviser in the sector of " Healthcare & Biotech " companies.